Oberweis Asset Management’s Antares Pharma, Inc. ATRS Stock Holding History

Oberweis Asset Management’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-344,200	Closed	-$1.41M	–	180
2022 Q1	$1.41M	Buy	344,200 +93,000	+37%	+$337K	0.28%	77
2021 Q4	$897K	Buy	251,200 +25,300	+11%	+$88.5K	0.16%	103
2021 Q3	$822K	Buy	225,900 +25,300	+13%	+$102K	0.17%	99
2021 Q2	$875K	Hold	200,600	–	–	0.19%	100
2021 Q1	$824K	Hold	200,600	–	–	0.17%	94
2020 Q4	$800K	Hold	200,600	–	–	0.21%	70
2020 Q3	$542K	Hold	200,600	–	–	0.18%	79
2020 Q2	$552K	Hold	200,600	–	–	0.22%	81
2020 Q1	$473K	Buy	200,600 +88,300	+79%	+$300K	0.26%	95
2019 Q4	$528K	Buy	+112,300	New	+$460K	0.18%	139

Other funds holding ATRS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Oberweis Asset Management's ATRS Position: Q2 2022 in Review

Oberweis Asset Management sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 344,200 shares — an estimated $1.41M sold.

Oberweis Asset Management first reported a position in ATRS in Q4 2019 and held it in 10 quarters. The position peaked at $1.41M in Q1 2022. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

Oberweis Asset Management reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
Oberweis Asset Management sold 344,200 Antares Pharma, Inc. shares in Q2 2022, an estimated $1.41M.
Oberweis Asset Management first reported a position in Antares Pharma, Inc. in Q4 2019 and held it in 10 quarters.
Oberweis Asset Management's Antares Pharma, Inc. position peaked at $1.41M in Q1 2022.
1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on Oberweis Asset Management's 13F filing for Q2 2022, filed 15 Aug 2022.